Skip to content
Stocks News
Enter Ticker Symbol
  • Home
  • FEATURED COMPANY
  • ANALYST COVERAGE
  • NEWS
  • SUBSCRIBE
  • CONTACT

ANALYST COVERAGE

cowen-maintains-buy-on-btsg-brightspring-health-services,-inc.-common-stock-mar-2026

Cowen Maintains Buy on BTSG BrightSpring Health Services, Inc. Common Stock Mar 2026

Mar 3, 2026

Cowen & Co. on March 2, 2026 maintained a Buy on BrightSpring Health Services, Inc. Common Stock (BTSG)…

Read more
cowen-maintains-buy-on-evolent-health-(evh)-march-2026,-pt-cut-to-$7

Cowen Maintains Buy on Evolent Health (EVH) March 2026, PT Cut to $7

Mar 3, 2026

On March 02, 2026 at 09:37 AM the EVH analyst rating from Cowen & Co. stayed at Buy…

Read more
osk-oshkosh-corporation:-raymond-james-maintains-outperform-march-2026

OSK Oshkosh Corporation: Raymond James Maintains Outperform March 2026

Mar 3, 2026

Raymond James maintained its Outperform rating on Oshkosh Corporation (OSK) on March 02, 2026. That is the lead…

Read more
craig-hallum-maintains-buy-on-globalstar-(gsat)-march-2026

Craig-Hallum Maintains Buy on Globalstar (GSAT) March 2026

Mar 3, 2026

Craig-Hallum maintained a Buy on Globalstar (GSAT) on March 2, 2026, and raised the price target to $70.…

Read more
william-blair-maintains-outperform-on-ocular-therapeutix,-inc.-(ocul)-march-2026

William Blair Maintains Outperform on Ocular Therapeutix, Inc. (OCUL) March 2026

Mar 3, 2026

On March 02, 2026 William Blair maintained an Outperform rating on Ocular Therapeutix, Inc. (OCUL), marking the most…

Read more
bofa-maintains-ntla-neutral-for-intellia-therapeutics-on-mar-2,-2026

BofA Maintains NTLA Neutral for Intellia Therapeutics on Mar 2, 2026

Mar 3, 2026

Bank of America Securities on March 2, 2026 maintained Neutral on Intellia Therapeutics (NTLA). This NTLA analyst rating…

Read more
william-blair-maintains-outperform-on-klaviyo,-inc-(kvyo)-march-2026

William Blair Maintains Outperform on Klaviyo, Inc (KVYO) March 2026

Mar 3, 2026

On March 02, 2026 William Blair maintained Outperform on Klaviyo, Inc. (KVYO) after the company announced a stock…

Read more
raymond-james-downgrades-avav-(aerovironment,-inc.)-to-underperform-march-2026

Raymond James Downgrades AVAV (AeroVironment, Inc.) to Underperform March 2026

Mar 3, 2026

The AVAV analyst rating moved sharply on March 02, 2026 when Raymond James downgraded AeroVironment, Inc. (AVAV) from…

Read more
outperform-maintained-on-asnd-ascendis-pharma-a/s-by-evercore-mar-02,-2026

Outperform Maintained on ASND Ascendis Pharma A/S by Evercore Mar 02, 2026

Mar 3, 2026

Evercore ISI maintained an Outperform rating on Ascendis Pharma A/S (ASND) on March 02, 2026 and raised its…

Read more
ubs-and-craig-hallum-maintain-buy-on-docebo-inc.-(dcbo)-march-2026

UBS and Craig-Hallum Maintain Buy on Docebo Inc. (DCBO) March 2026

Mar 3, 2026

UBS and Craig-Hallum maintained a Buy rating on Docebo Inc. (DCBO) on March 02, 2026. The DCBO analyst…

Read more
goldman-sachs-maintains-buy-on-adt-(adt-inc.)-march-2026

Goldman Sachs Maintains Buy on ADT (ADT Inc.) March 2026

Mar 3, 2026

Goldman Sachs maintained a Buy on ADT (ADT Inc.) on March 02, 2026 after flagging possible negative investor…

Read more
cowen-maintains-hold-on-purecycle-technologies,-inc.-(pct)-march-2026

Cowen Maintains Hold on PureCycle Technologies, Inc. (PCT) March 2026

Mar 3, 2026

On March 2, 2026, Cowen & Co. maintained a Hold on PureCycle Technologies, Inc. (PCT) and lowered its…

Read more
  1. Pages:
  2. «
  3. 1
  4. ...
  5. 108
  6. 109
  7. 110
  8. 111
  9. 112
  10. 113
  11. 114
  12. ...
  13. 465
  14. »

Posts pagination

Newer posts Page 1 … Page 111 … Page 465 Older posts

The content presented on this site is intended solely for entertainment purposes and should not be construed as an invitation to engage in the purchase or sale of securities. Each content provider featured on 10x Wealth Report brings a unique perspective and predisposition, which may not necessarily align with that of 10x Wealth Report. It is crucial to recognize that 10x Wealth Report is not a registered financial advisor or firm. Read More full disclaimer

CATEGORIES

  • FEATURED COMPANY
  • NEWS
  • ANALYST COVERAGE
  • Special Post
  • CONTACT
  • SUBSCRIBE
  • Privacy Policy
  • Terms or Service
  • Disclaimer

CONNECT & FOLLOW

© 10x Wealth Report Copyright 2024.